STRATEC Biomedical acquisition of Diatron

Overview:

• STRATEC Biomedical has acquired Diatron for an undisclosed fee from The Riverside Company.
• Diatron, based in Budapest, designs and manufactures system solutions for hematology applications, as well as related consumables.
• STRATEC designs and manufactures fully automated analyzer systems in the fields of clinical diagnostics and biotechnology.
• UniCredit provided the financing for the acquisition.

Sam Duke - Editor